Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 30, Status: Authorised

Submitted by Anonymous (not verified) on 10 November 2025 - 15:00

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Dectova, zanamivir, Date of authorisation: 26/04/2019, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 10 November 2025 - 14:25

Human medicines European public assessment report (EPAR): Dectova, zanamivir, Date of authorisation: 26/04/2019, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 10 November 2025 - 11:22

Human medicines European public assessment report (EPAR): Oyavas, bevacizumab, Date of authorisation: 26/03/2021, Revision: 8, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness